April 2, 2019 Acad, Gov/Utilities Forensics & Security M&A, Partnerships Molecular Spectroscopy

Handheld Raman Analyzer from Rigaku Analytical Devices Chosen as Part of U.S. Department of Defense Tech Refresh Program

The Rigaku Progeny ResQ 1064 nm handheld Raman analyzer will be deployed globally as part of the U.S. Army’s Dismounted Reconnaissance Sets, Kits, and Outfits (DRSKO) Program Wilmington, MA (April 2, 2019) – Rigaku Analytical Devices, a U.S.-based, leading pioneer of handheld and portable spectroscopic analyzers, is pleased to announce they will provide the Rigaku... Read more

April 1, 2019 Acad, Gov/Utilities Clinical Research/Diagn. Lab Top-10 Product Launch

New Expanded Analytical Instrument Portfolio of U.S. FDA Class I Medical Devices for Clinical Diagnostic Laboratories

New Expanded Analytical Instrument Portfolio of U.S. FDA Class I Medical Devices for Clinical Diagnostic Laboratories Thermo Scientific Medical Device portfolio provides an extensive range of chromatography and mass spectrometry instruments for laboratory development test optimization PALM SPRINGS, Calif., April 1, 2019 /PRNewswire/ — MSACL US 2019 – Thermo Fisher Scientific announces the expansion of its portfolio... Read more

March 25, 2019 Acad, Gov/Utilities Atomic Spectroscopy Mass Spectrometry Molecular Spectroscopy

New Center for Spectroscopic Excellence

By John Burchell / March 25, 2019 Home / News / New Center for Spectroscopic Excellence JASCO Corporation (Tokyo Japan) is proud to announce a joint collaboration with the Department of Chemistry at the prestigious University of Pennsylvania (Philadelphia). The New Center for Spectroscopic Excellence was inaugurated at the end of March 2019. We are pleased to be working with the researchers... Read more

March 20, 2019 Acad, Gov/Utilities Lab Top-10 Liq. Handling & Robotics

PerkinElmer Receives FDA Clearance for EUROIMMUN Anti-Tissue Transglutaminase ELISA

Serological testing plays critical role in helping diagnose patients with celiac disease WHAT: PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced that its EUROIMMUN Anti-TissueTransglutaminase (tTG) ELISA has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). The test system is designed to help clinicians confirm or exclude... Read more

March 20, 2019 Acad, Gov/Utilities Chromatography Informatics & Software Lab Top-10 Mass Spectrometry Product Launch

Shimadzu Releases New Multi-Omic Data Analysis Package and Relevant Method Packages in Cooperation with the Systems Biology Institute and Osaka University

March 20, 2019 Shimadzu Corporation (head office: Kyoto city; President and CEO: Teruhisa Ueda) announces the release of a Multi-Omic Data Analysis Package designed for metabolic engineering research applications. Using this package, measurement data from Shimadzu mass spectrometers can be loaded in the Garuda*1 open platform and automatically plotted on a metabolic map. The package can... Read more

March 19, 2019 Acad, Gov/Utilities

FDA approves Roche’s Tecentriq in combination with chemotherapy for the initial treatment of adults with extensive-stage small cell lung cancer

Basel, 19 March 2019 FDA approves Roche’s Tecentriq in combination with chemotherapy for the initial treatment of adults with extensive-stage small cell lung cancer Tecentriq in combination with chemotherapy (carboplatin and etoposide) is the first and only cancer immunotherapy approved for the initial treatment of extensive-stage small cell lung cancer (ES-SCLC) First new initial treatment... Read more

March 14, 2019 Acad, Gov/Utilities Bio/Pharma/CRO PR/Corporate

BD Receives U.S. FDA Approval for First Venous Stent to Treat Iliofemoral Venous Occlusive Disease

FRANKLIN LAKES, N.J., March 14, 2019 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the U.S. Food and Drug Administration has granted premarket approval for the Venovo™ venous stent, the first stent indicated to treat iliofemoral venous occlusive disease, which is obstructed or narrowed blood flow specific to... Read more

March 11, 2019 Acad, Gov/Utilities Licensing, IP, and Legal

FDA grants Roche’s Tecentriq in combination with Abraxane accelerated approval for people with PD-L1-positive, metastatic triple-negative breast cancer

Basel, 11 March 2019 FDA grants Roche’s Tecentriq in combination with Abraxane accelerated approval for people with PD-L1-positive, metastatic triple-negative breast cancer This Tecentriq combination is the first cancer immunotherapy regimen approved for breast cancer Triple-negative breast cancer is an aggressive disease, with high unmet medical need Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced... Read more

March 7, 2019 Acad, Gov/Utilities Product Launch

Roche submits supplemental new drug application to FDA for Venclexta plus Gazyva for previously untreated chronic lymphocytic leukaemia with co-existing medical conditions

Basel, 07 March 2019 Roche submits supplemental new drug application to FDA for Venclexta plus Gazyva for previously untreated chronic lymphocytic leukaemia with co-existing medical conditions Application is being reviewed under FDA’s Real-Time Oncology Review pilot programme Combination was granted Breakthrough Therapy Designation, the fifth for Venclexta Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced... Read more

March 7, 2019 Acad, Gov/Utilities Lab Top-10

MilliporeSigma Brings Science Education to Students Across North America with Curiosity Cube® Mobile Science Lab

Burlington, Massachusetts, March 7, 2019 — MilliporeSigma is igniting student interest in science with its third annual Curiosity Cube® mobile science lab tour. “We’ve seen firsthand how the interactive learning that takes place inside the Curiosity Cube® can spark curiosity crucial for developing a passion for science,” said Udit Batra, CEO, MilliporeSigma. “We will continue to... Read more